Article
Genome-wide association study of treatment-related toxicity two years following radiotherapy for breast cancer.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology - 1 Oct 2023
Jandu Harkeran K, Veal Colin D, Fachal Laura, Luccarini Craig, Aguado-Barrera Miguel E, Altabas Manuel, Azria David, Baten Adinda, Bourgier Celine, Bultijnck Renée, Colciago Riccardo R, Farcy-Jacquet Marie-Pierre, Chang-Claude Jenny, Choudhury Ananya, Dunning Alison, Elliott Rebecca M, Green Sheryl, Gutiérrez-Enríquez Sara, Herskind Carsten, Lambrecht Maarten, Monten Christel, Rancati Tiziana, Reyes Victoria, Rosenstein Barry S, De Ruysscher Dirk, Carmen De Santis Maria, Seibold Petra, Sperk Elena, Veldwijk Marlon, Paul Symonds R, Stobart Hilary, Taboada-Valladares Begoña, Vega Ana, Veldeman Liv, Webb Adam J, Weltens Caroline, West Catharine M, Rattay Tim, Talbot Christopher J
Abstract excerpt
BACKGROUND AND PURPOSE: Up to a quarter of breast cancer patients treated by surgery and radiotherapy experience clinically significant toxicity. If patients at high risk of adverse effects could be identified at diagnosis, their treatment could be tailored accordingly. This study was designed to identify common single nucleotide polymorphisms (SNPs) associated with toxicity two years following whole breast...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.